{"gene":"NMNAT1","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2001,"finding":"NMNAT1 (Nmnat) is the active neuroprotective component of the WldS chimeric protein (Ube4b/Nmnat fusion); the WldS protein is located predominantly in the nucleus and Nmnat enzyme activity is increased fourfold in WldS tissues, indicating axon protection is mediated through altered pyridine nucleotide metabolism.","method":"Transgenic mouse overexpression; biochemical enzyme activity assay; subcellular localization by immunofluorescence","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — identification of the protective gene, dose-dependent protection shown in transgenic mice, enzyme activity measured, replicated across multiple labs","pmids":["11770485"],"is_preprint":false},{"year":2001,"finding":"Human NMNAT1 is a nuclear enzyme (confirmed by immunofluorescence of nuclear localization signal) that catalyzes NAD+ synthesis from ATP and NMN; recombinant NMNAT1 strongly inhibits PARP1 activity in vitro; endogenous and recombinant NMNAT1 are phosphorylated by nuclear kinases in nuclear extracts.","method":"Protein purification from human placenta; recombinant expression; immunofluorescence; in vitro PARP1 inhibition assay; [γ-32P]ATP phosphorylation assay in nuclear extracts","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Strong — purified enzyme, in vitro activity assays, direct localization experiment, multiple orthogonal methods in a single rigorous study","pmids":["11248244"],"is_preprint":false},{"year":2006,"finding":"Phe28 of mouse Nmnat1 is critical for enzymatic activity; the Phe28 point mutation in WldS completely abolishes Nmnat enzyme activity and eliminates axon-protective function, confirming that Nmnat1 enzymatic activity is required for WldS-mediated axon protection.","method":"Site-directed mutagenesis; in vitro enzyme activity assay; herpes virus-mediated neuronal expression with axon degeneration morphological assay","journal":"Neuroscience letters","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — active-site mutagenesis with enzymatic and functional readout, but single lab, single paper","pmids":["17207927"],"is_preprint":false},{"year":2006,"finding":"In Drosophila, enzymatically inactive NMNAT protein retains significant neuroprotective effects and rescues neurodegeneration caused by loss of nmnat, demonstrating an NAD-independent requirement of NMNAT for maintaining neuronal integrity.","method":"Forward genetic screen for nmnat loss-of-function mutations in Drosophila; rescue experiments with enzyme-dead NMNAT in vivo","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — first nmnat loss-of-function mutations in a multicellular organism, rescue with enzyme-dead protein, multiple neuron types examined","pmids":["17132048"],"is_preprint":false},{"year":2008,"finding":"NMNAT displays chaperone function in biochemical assays and cultured cells; it shares structural similarity with known chaperones, is upregulated in the brain upon polyglutamine-expanded protein overexpression, and is recruited with Hsp70 into protein aggregates, acting through a proteasome-mediated pathway similar to Hsp70.","method":"Biochemical chaperone assays; cell culture; co-localization with Hsp70 in protein aggregates; proteasome pathway inhibition","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical chaperone assay plus in vivo Drosophila experiments, multiple orthogonal methods, high-impact journal","pmids":["18344983"],"is_preprint":false},{"year":2009,"finding":"WldS-mediated suppression of Wallerian degeneration requires both Nmnat1 enzymatic activity and interaction of the N16 domain of WldS with valosin-containing protein (VCP)/TER94; enzyme-dead versions of Nmnat1 and WldS exhibit severely reduced axon-protective function in Drosophila.","method":"In vivo Drosophila axon protection assay; enzyme-dead mutant analysis; N16 domain deletion and VCP-binding domain replacement","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple domain mutants tested in vivo, VCP interaction confirmed by domain swap, replicated in complementary mouse paper (PMID 19237596)","pmids":["19237597"],"is_preprint":false},{"year":2009,"finding":"In mice, WldS requires both Nmnat1 enzymatic activity and the VCP-binding sequence from the N-terminal Ube4b domain for axon protection; removing the VCP-binding sequence abolishes protection, and replacing it with an ataxin-3-derived VCP-binding sequence restores it; enzyme-dead WldS cannot delay Wallerian degeneration in vivo.","method":"In vivo transgenic mouse sciatic nerve transection model; VCP-binding domain deletion and substitution mutants","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo mouse experiments with multiple domain mutants, complementary to Drosophila study (PMID 19237597)","pmids":["19237596"],"is_preprint":false},{"year":2009,"finding":"Cytoplasmic/axonally localized Nmnat1 (cytNmnat1) is sufficient to delay Wallerian degeneration in vivo in transgenic mice without any Ube4b sequences, demonstrating that Nmnat enzymatic activity outside the nucleus is required and sufficient for axon protection.","method":"Transgenic mouse generation with cytoplasmic-targeted Nmnat1; sciatic nerve transection; microscopic analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo transgenic mouse model with engineered localization mutant, clear phenotypic readout","pmids":["19458223"],"is_preprint":false},{"year":2010,"finding":"Axonal targeting of NMNAT1 activity is both necessary and sufficient for axon protection; fusing an axonal targeting peptide from APP to NMNAT1 with disrupted nuclear localization transforms it from an ineffective molecule into one more potent than WldS in transgenic mice; axonally targeted NMNAT1 localizes to vesicular structures and co-transports at least partially with mitochondria.","method":"Transgenic mouse generation; axonal targeting peptide fusion; subcellular localization by live imaging; sciatic nerve transection assay","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo transgenic mouse experiment with engineered subcellular localization, multiple orthogonal methods, functional and localization readout","pmids":["20926655"],"is_preprint":false},{"year":2010,"finding":"Transduction of Nmnat protein directly into severed axons via virus-like particles prevents axonal degeneration post-injury, establishing that Nmnat's protective effects occur locally within the axon.","method":"Protein transduction via virus-like particles into transected axons; in vitro axon degeneration assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct protein transduction into axons is a novel method establishing local axonal action, single lab single study","pmids":["21071441"],"is_preprint":false},{"year":2011,"finding":"NMNAT1 interacts with the nucleolar repressor nucleomethylin and is recruited into a ternary complex containing SirT1; NMNAT1 expression stimulates the deacetylase function of SirT1; NMNAT1 is involved in repressing rRNA transcription, and knockdown enhances rRNA transcription and promotes cell death after nutrient deprivation.","method":"Co-immunoprecipitation; knockdown; rRNA transcription assay; SirT1 deacetylase activity assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — reciprocal Co-IP and functional enzyme assay, single lab, moderate mechanistic follow-up","pmids":["23737528"],"is_preprint":false},{"year":2012,"finding":"Loss-of-function mutations in NMNAT1 (LCA9 locus) cause Leber congenital amaurosis; the disease-causing p.Val9Met mutation decreases NMNAT1 enzyme activity, establishing that reduced NAD+ biosynthetic activity of NMNAT1 underlies retinal degeneration.","method":"Exome sequencing; functional enzyme activity assay of mutant NMNAT1 protein","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — functional enzymatic assay of mutant protein, replicated in three independent papers in the same journal issue (PMIDs 22842227, 22842230, 22842231)","pmids":["22842227","22842230","22842231"],"is_preprint":false},{"year":2012,"finding":"LCA-causing NMNAT1 mutations reduce enzymatic activity and affect protein folding, as assessed by functional assays of mutant alleles.","method":"Functional enzyme activity assay; protein folding assessment of LCA mutant proteins","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro enzyme assay plus protein folding analysis, replicated across independent cohort papers","pmids":["22842230"],"is_preprint":false},{"year":2012,"finding":"The E3 ubiquitin ligase Highwire (Hiw) promotes rapid degradation of Nmnat protein in the distal axon stump after injury; increased Nmnat protein levels in hiw mutants are both required and sufficient to inhibit Wallerian degeneration, placing Nmnat downstream of Hiw in the axon degeneration pathway.","method":"Drosophila genetic epistasis; hiw loss-of-function and gain-of-function; protein level measurement by western blot; in vivo axon degeneration assay","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with multiple neuron types and developmental stages, rescue experiments, mechanistic pathway placement","pmids":["23226106"],"is_preprint":false},{"year":2016,"finding":"NMNAT1 overexpression protects injured axons by blocking SARM1-dependent NAD+ consumption (rather than by increasing NAD+ synthesis); using steady-state and flux analysis, NMNAT1 was found to inhibit injury-induced, SARM1-mediated NAD+ depletion that is central to axon degeneration.","method":"Steady-state and metabolic flux analysis of NAD+ metabolites in mouse DRG axons; SARM1 genetic manipulation","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Strong — metabolic flux analysis with genetic manipulation of SARM1, mechanistic pathway placement, rigorous quantitative methods","pmids":["27735788"],"is_preprint":false},{"year":2020,"finding":"NMNAT1 loss in photoreceptors activates the NADase SARM1 (the central executioner of axon degeneration), triggering photoreceptor death; SARM1 depletion rescues photoreceptor loss in NMNAT1-deficient retinas, establishing that NMNAT1's essential function in photoreceptors is to inhibit SARM1.","method":"Conditional knockout mice; SARM1 genetic depletion rescue experiment; photoreceptor-specific conditional deletion","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with genetic rescue by SARM1 depletion, multiple mouse models, clear mechanistic pathway","pmids":["33107823"],"is_preprint":false},{"year":2015,"finding":"Most LCA-associated NMNAT1 mutants have normal enzymatic activity under standard conditions, but their secondary structure is less thermally stable (they lose activity after heat shock while wild-type retains activity), suggesting protein instability rather than direct loss of catalytic activity is a mechanism underlying retinal degeneration.","method":"Recombinant protein expression; enzyme activity assay; heat shock stability assay; secondary structure analysis; oligomerization assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — multiple biochemical assays on LCA mutants, single lab, comprehensive but not independently replicated","pmids":["26018082"],"is_preprint":false},{"year":2011,"finding":"NMNAT overexpression suppresses tauopathy-induced neurodegeneration by reducing hyperphosphorylated tau oligomer levels; NMNAT interacts with phosphorylated tau in vivo and promotes ubiquitination and clearance of toxic tau species; this protective activity is independent of NAD synthesis activity, indicating direct protein-protein interaction.","method":"Drosophila tauopathy model; overexpression with enzyme-dead NMNAT; co-immunoprecipitation with phospho-tau in vivo; ubiquitination assay","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP in vivo plus enzyme-dead rescue plus ubiquitination assay, single lab but multiple orthogonal methods","pmids":["21965302"],"is_preprint":false},{"year":2021,"finding":"NMNAT promotes autophagic clearance of mutant Huntingtin aggregates in Drosophila HD models; it reduces the amyloid-like adhesive property of Htt aggregates and inhibits their clustering with mitochondria and synaptic proteins; partial loss of endogenous Nmnat exacerbates mutant Htt-induced neurodegeneration.","method":"Drosophila HD model; Nmnat overexpression and partial loss-of-function; autophagy assay; thioflavin S staining for amyloid-like aggregates; mitochondrial clustering analysis","journal":"Proceedings of the National Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple Drosophila genetic approaches with orthogonal readouts, single lab","pmids":["31484760"],"is_preprint":false},{"year":2021,"finding":"NMNAT interferes with the DNA damage-p53-caspase-3 apoptosis pathway by enhancing NAD+-dependent post-translational modifications: PARylation and deacetylation of p53, which reduce p53 pro-apoptotic activity; NMNAT forms a protein complex with p53 and NAD+-dependent PTM enzymes.","method":"Drosophila glial neoplasia model and human glioma cells; co-immunoprecipitation; p53 PARylation and deacetylation assays; enzyme-dead NMNAT controls","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus functional PTM assays in two model systems, single lab","pmids":["34919052"],"is_preprint":false},{"year":2021,"finding":"NMNAT1 knockout in the developing murine retina causes disruptions to central carbon metabolism, purine nucleotide synthesis, and amino acid pathways; transcriptomic analysis reveals dysregulation of photoreceptor and synapse-specific genes prior to detectable morphological or metabolic changes, suggesting a role in gene regulation during photoreceptor terminal differentiation.","method":"Conditional knockout mice; transcriptomics (RNA-seq); metabolomics; immunostaining","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with transcriptomic and metabolomic analysis, single lab, multiple orthogonal methods","pmids":["34878972"],"is_preprint":false},{"year":2021,"finding":"NMNAT1 loss in photoreceptors leads to a retina-specific decrease in NAD+ and overproduction of poly(ADP-ribose) (PAR) by PARP in photoreceptors, while nuclear sirtuin deacetylation activity is not altered; photoreceptors ultimately die by apoptosis, with aspects of the parthanatos pathway.","method":"Mouse model (p.Val9Met); LC-MS/MS quantification of NAD+; PARP activity assay; PAR immunostaining; TUNEL staining","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — quantitative metabolite measurement plus PARP activity assay, single lab single paper","pmids":["33709122"],"is_preprint":false},{"year":2024,"finding":"NMNAT1 is lactylated at Lys128 by the lactyltransferase EP300; lactylation of NMNAT1 enhances its nuclear localization and maintains its enzymatic activity, thereby supporting the nuclear NAD+ salvage pathway in pancreatic cancer cells under glucose deprivation.","method":"Multi-omics analysis; site-directed mutagenesis at K128; RNA interference; co-immunoprecipitation with EP300; subcellular fractionation; enzyme activity assay","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-directed mutagenesis identifying modification site, EP300 identified as writer by Co-IP, functional enzyme and localization assays, single lab","pmids":["38467179"],"is_preprint":false},{"year":2024,"finding":"NMNAT1 is essential for human iPSC differentiation to the retinal lineage; NMNAT1-KO organoids fail to induce RAX and form retinal primordial structures; NMNAT1-KO leads to decreased NAD+ levels and reduced PARylation of PARP1, identifying a NMNAT1-NAD-PARP1 axis in retinal fate commitment.","method":"CRISPR/Cas9 NMNAT1-KO human iPSC retinal organoids; transcriptomic analysis; mass spectrometry of PARylated proteins; intracellular NAD measurement","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO in human iPSCs with multiple orthogonal readouts, single lab","pmids":["39446354"],"is_preprint":false},{"year":2001,"finding":"Human NMNAT1 was crystallized in the presence of NAD+; crystals diffract to 3.0 Å resolution, and packing considerations suggest a hexameric assembly in the asymmetric unit, consistent with archaeal NMNAT hexamers.","method":"Protein crystallization; preliminary X-ray diffraction analysis","journal":"Acta crystallographica Section D","confidence":"Low","confidence_rationale":"Tier 1 / Weak — preliminary crystallography only, no functional validation, resolution insufficient for full structure determination at this stage","pmids":["11752792"],"is_preprint":false},{"year":2025,"finding":"NMNAT1 binds to promoters and enhancers of actively transcribed genes genome-wide; NMNAT1 knockout reduces RNA Polymerase II occupancy at downregulated genes, positioning NMNAT1 as coupling localized NAD+ production to gene-specific transcriptional activation through Pol II engagement.","method":"CUT&Tag (genome-wide NMNAT1 binding); RNA-seq; NMNAT1 knockout cells; multi-omics integration","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — CUT&Tag plus RNA-seq in KO cells, preprint not yet peer-reviewed, single lab","pmids":["40654636"],"is_preprint":true},{"year":2026,"finding":"AMI-1 (a known PRMT1 inhibitor) also inhibits NMNAT1; cryo-EM structure of NMNAT1 bound to AMI-1 reveals its mechanism of inhibition at atomic resolution.","method":"Cryo-EM structure determination; biochemical inhibition assay; NAD+ level measurement in NMNAT1-dependent cancer cells","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — cryo-EM structure with functional inhibition assay, preprint not peer-reviewed, single lab","pmids":["41993279"],"is_preprint":true},{"year":2025,"finding":"KNOP1 directly interacts with NMNAT1 to maintain intracellular NAD+ homeostasis; this interaction inhibits FoxO1 phosphorylation and promotes its nuclear retention, facilitating GPX4 transcription and suppressing ferroptosis in breast cancer cells; NMNAT1 knockdown disrupts this axis by inducing FoxO1 nuclear export and GPX4 downregulation.","method":"Co-immunoprecipitation; ChIP; NAD+ quantification; RNA interference; rescue experiments with Ferrostatin-1 and NMNAT1 overexpression","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus ChIP plus rescue experiments, multiple orthogonal methods, single lab","pmids":["40784594"],"is_preprint":false},{"year":2026,"finding":"Reduced NMNAT1 function (p.V9M mutation) leads to accumulation of oxidative DNA adduct 8-oxo-dG and DNA double-strand breaks in photoreceptors, followed by caspase-9-mediated apoptosis; necroptosis and parthanatos pathways are not significantly activated; treatment with antioxidant NAC reduces oxidative DNA damage and preserves photoreceptor structure and function.","method":"Nmnat1 V9M/V9M knock-in mice; 8-oxo-dG immunostaining; γH2AX staining; caspase-9 activation assay; TUNEL; NAC treatment; OCT and ERG","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal cell death pathway assays in knock-in mouse model with therapeutic intervention, single lab","pmids":["41922335"],"is_preprint":false}],"current_model":"NMNAT1 is a nuclear NAD+-synthesizing enzyme (catalyzing the adenylylation of NMN to NAD+) that maintains nuclear NAD+ homeostasis and protects neurons—particularly retinal photoreceptors—by inhibiting the NADase SARM1 and thereby blocking injury- or stress-induced NAD+ depletion; it also functions as a molecular chaperone independent of its enzymatic activity, promotes clearance of misfolded proteins via autophagy and the ubiquitin-proteasome system, stimulates SirT1 deacetylase activity within a nucleomethylin-containing complex to repress rRNA transcription, and binds promoters/enhancers to couple local NAD+ production to RNA Polymerase II engagement, while its axon-protective activity requires cytoplasmic/axonal localization and is regulated by Highwire-mediated ubiquitin-dependent degradation."},"narrative":{"mechanistic_narrative":"NMNAT1 is a nuclear enzyme that synthesizes NAD+ from ATP and NMN and serves as a central guardian of neuronal integrity and NAD+ homeostasis [PMID:11248244, PMID:11770485]. Its identification as the active component of the WldS axon-protective fusion protein established that altered pyridine nucleotide metabolism delays axon degeneration, with enzymatic activity required for this protection [PMID:11770485, PMID:17207927, PMID:19237597]. Although NMNAT1 is constitutively nuclear, its axon-protective function depends on activity localized outside the nucleus: cytoplasmic and axonally targeted NMNAT1 is sufficient to delay Wallerian degeneration and acts locally within the axon [PMID:19458223, PMID:20926655, PMID:21071441]. Mechanistically, NMNAT1 protects injured axons not by boosting NAD+ synthesis but by blocking SARM1-dependent NAD+ depletion, the central degenerative trigger; loss of NMNAT1 activates the NADase SARM1, and SARM1 depletion rescues photoreceptor death in NMNAT1-deficient retinas [PMID:27735788, PMID:33107823]. Independent of its catalytic activity, NMNAT1 functions as a molecular chaperone that is recruited with Hsp70 into protein aggregates and promotes clearance of misfolded proteins, including phospho-tau and mutant Huntingtin, through the ubiquitin-proteasome system and autophagy [PMID:18344983, PMID:21965302, PMID:31484760]. In the nucleus, NMNAT1 couples local NAD+ production to gene regulation: it associates with the nucleomethylin/SirT1 complex to repress rRNA transcription, stimulates SirT1 deacetylase activity, and dampens p53-driven apoptosis via NAD+-dependent PARylation and deacetylation [PMID:23737528, PMID:34919052]. In humans, loss-of-function mutations in NMNAT1 cause Leber congenital amaurosis, with disease alleles reducing enzymatic activity and/or destabilizing the protein [PMID:22842227, PMID:22842230, PMID:22842231, PMID:26018082]; in the retina, NMNAT1 deficiency drives NAD+ decline, oxidative DNA damage, and photoreceptor apoptosis [PMID:33709122, PMID:41922335].","teleology":[{"year":2001,"claim":"Established that NMNAT1 is the functional neuroprotective effector of the WldS protein, linking axon protection to NAD+ metabolism, and defined NMNAT1 as a nuclear NAD+-synthesizing enzyme.","evidence":"Transgenic mouse overexpression with enzyme activity assays and immunofluorescence; protein purification from human placenta with in vitro NAD+ synthesis and PARP1 inhibition assays","pmids":["11770485","11248244"],"confidence":"High","gaps":["Nuclear localization seemed incompatible with axon protection occurring in the cytoplasm","Whether enzymatic activity per se was required was not yet resolved"]},{"year":2006,"claim":"Tested whether catalysis is required for protection, with conflicting answers that defined a dual-function model: enzyme activity is needed for WldS axon protection in mice, yet enzyme-dead NMNAT still rescues neurodegeneration in Drosophila.","evidence":"Site-directed active-site mutagenesis (Phe28) with neuronal axon degeneration assays in mice; forward genetic loss-of-function screen and enzyme-dead rescue in Drosophila","pmids":["17207927","17132048"],"confidence":"High","gaps":["The molecular basis of the NAD-independent neuroprotective activity was undefined","Did not resolve whether the two activities act in the same or different cell compartments"]},{"year":2008,"claim":"Identified the NAD-independent activity as a chaperone function, explaining how NMNAT can protect neurons without synthesizing NAD+.","evidence":"Biochemical chaperone assays, co-localization with Hsp70 in aggregates, and proteasome pathway inhibition in cultured cells","pmids":["18344983"],"confidence":"High","gaps":["The structural determinants of chaperone activity were not mapped","Direct substrate range of the chaperone function was not defined"]},{"year":2009,"claim":"Dissected the WldS protective module, showing protection requires both NMNAT1 catalysis and the N16/Ube4b VCP-binding sequence, and that cytoplasmic NMNAT1 alone suffices for axon protection.","evidence":"In vivo Drosophila and transgenic mouse axon protection assays with domain deletions, VCP-binding domain swaps, enzyme-dead mutants, and cytoplasmic-targeted NMNAT1","pmids":["19237597","19237596","19458223"],"confidence":"High","gaps":["How VCP interaction mechanistically cooperates with NAD+ synthesis was not established","The endogenous compartment in which NMNAT1 acts during physiological injury was unclear"]},{"year":2010,"claim":"Demonstrated that axonal/local targeting of NMNAT1 activity is necessary and sufficient and that protection occurs locally within the axon, refining where the enzyme must act.","evidence":"Transgenic mice with axonal targeting peptide fusions and disrupted NLS, live imaging of vesicular/mitochondrial co-transport; protein transduction into severed axons via virus-like particles","pmids":["20926655","21071441"],"confidence":"High","gaps":["The axonal vesicular/mitochondrial association mechanism was not molecularly defined","Protein-transduction study was a single-lab in vitro demonstration"]},{"year":2011,"claim":"Connected nuclear NMNAT1 to gene regulation and protein clearance, showing it stimulates SirT1 to repress rRNA transcription and promotes ubiquitin-dependent clearance of toxic phospho-tau independent of NAD synthesis.","evidence":"Co-immunoprecipitation, knockdown, rRNA transcription and SirT1 deacetylase assays; Drosophila tauopathy model with enzyme-dead NMNAT, in vivo phospho-tau Co-IP and ubiquitination assays","pmids":["23737528","21965302"],"confidence":"Medium","gaps":["Single-lab Co-IP evidence without structural detail of the ternary complex","Whether SirT1 stimulation and tau clearance operate in the same pathway is unknown"]},{"year":2012,"claim":"Established NMNAT1 as a Mendelian disease gene, showing loss-of-function mutations cause Leber congenital amaurosis through reduced NAD+ biosynthetic activity and impaired protein folding.","evidence":"Exome sequencing of LCA patients and functional enzyme activity plus protein folding assays of mutant alleles, replicated across independent cohort papers","pmids":["22842227","22842230","22842231"],"confidence":"High","gaps":["Why a ubiquitous enzyme causes a retina-specific disease was unexplained","The downstream degenerative pathway in photoreceptors was not yet defined"]},{"year":2012,"claim":"Placed NMNAT in an injury-signaling pathway by showing the E3 ligase Highwire drives its rapid post-injury degradation, identifying regulated NMNAT turnover as a control point for axon degeneration.","evidence":"Drosophila genetic epistasis with hiw loss- and gain-of-function, protein-level western blots, and in vivo axon degeneration assays","pmids":["23226106"],"confidence":"High","gaps":["Whether a mammalian Highwire ortholog regulates NMNAT1 the same way was not tested here","The signal triggering Hiw-dependent NMNAT degradation was unknown"]},{"year":2016,"claim":"Redefined the protective mechanism, showing NMNAT1 prevents axon degeneration by blocking SARM1-mediated NAD+ depletion rather than by net NAD+ synthesis.","evidence":"Steady-state and metabolic flux analysis of NAD+ metabolites in mouse DRG axons with SARM1 genetic manipulation","pmids":["27735788"],"confidence":"High","gaps":["The direct biochemical relationship between NMNAT1 and SARM1 was not structurally resolved","How NMNAT1 levels are coupled to SARM1 activation kinetics was not detailed"]},{"year":2015,"claim":"Refined the disease mechanism by showing most LCA mutants retain catalytic activity but are thermally unstable, implicating protein destabilization rather than direct catalytic loss.","evidence":"Recombinant mutant protein enzyme, heat-shock stability, secondary structure, and oligomerization assays","pmids":["26018082"],"confidence":"Medium","gaps":["Single-lab biochemistry not independently replicated","Did not test instability in photoreceptors in vivo"]},{"year":2020,"claim":"Identified SARM1 inhibition as the essential function of NMNAT1 in photoreceptors, explaining retinal vulnerability in NMNAT1 deficiency.","evidence":"Photoreceptor-specific conditional knockout mice with genetic SARM1-depletion rescue","pmids":["33107823"],"confidence":"High","gaps":["Whether SARM1 fully accounts for human LCA pathology was not established","The relative contribution of nuclear vs cytoplasmic NMNAT1 in photoreceptors was not dissected"]},{"year":2021,"claim":"Expanded the functional repertoire to autophagic aggregate clearance, p53/apoptosis regulation, and photoreceptor metabolic/transcriptional roles, and detailed retinal degeneration involving NAD+ decline and PARP overactivation.","evidence":"Drosophila HD and glioma models with autophagy, PARylation/deacetylation and Co-IP assays; conditional KO retinal transcriptomics/metabolomics; mouse p.Val9Met NAD+/PARP/PAR/TUNEL analyses","pmids":["31484760","34919052","34878972","33709122"],"confidence":"Medium","gaps":["These roles rest largely on single-lab studies in disparate model systems","How nuclear NAD+ depletion mechanistically links to PARP overactivation and cell death is incompletely defined"]},{"year":2024,"claim":"Began defining regulation and chromatin-coupled roles of NMNAT1, showing EP300-mediated lactylation maintains nuclear activity, NMNAT1 is required for retinal lineage commitment via a NAD-PARP1 axis, and it binds active promoters to couple NAD+ production to Pol II engagement.","evidence":"Lactylation site mutagenesis with EP300 Co-IP and fractionation; CRISPR-KO iPSC retinal organoids with NAD+/PARylation readouts; CUT&Tag with RNA-seq in KO cells (preprint)","pmids":["38467179","39446354","40654636"],"confidence":"Medium","gaps":["The genome-wide chromatin-binding model derives from a preprint","How NMNAT1 is recruited to specific promoters/enhancers is unknown"]},{"year":2026,"claim":"Advanced structural and cell-death mechanism understanding, providing a cryo-EM structure of inhibitor-bound NMNAT1 and showing the V9M retinal phenotype proceeds via oxidative DNA damage and caspase-9 apoptosis rescuable by antioxidant treatment.","evidence":"Cryo-EM of NMNAT1-AMI-1 with biochemical inhibition assays (preprint); V9M knock-in mice with 8-oxo-dG, γH2AX, caspase-9, TUNEL assays and NAC intervention","pmids":["41993279","41922335"],"confidence":"Medium","gaps":["Cryo-EM inhibitor study is a non-peer-reviewed preprint","Reconciling the oxidative-DNA-damage/caspase-9 mechanism with the SARM1-dependent model remains open"]},{"year":null,"claim":"How NMNAT1's distinct activities — nuclear NAD+ synthesis, SARM1 inhibition, NAD-independent chaperone/aggregate clearance, and promoter-coupled transcriptional regulation — are integrated, compartmentally partitioned, and selectively deployed in a cell-type-specific manner remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified structural/mechanistic model links NMNAT1's enzymatic and chaperone functions","The basis for retina-specific vulnerability despite ubiquitous expression is incompletely explained","Direct physical interaction mode with SARM1 is undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[1,0,11]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[4,17,18]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,10,14]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[25]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,0]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[7,8]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[10]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,14,20]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[19,28,21]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[11,12,15]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[10,25]}],"complexes":["nucleomethylin/SirT1 complex"],"partners":["SARM1","PARP1","SIRT1","VCP","HSP70","EP300","TP53","KNOP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9HAN9","full_name":"Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1","aliases":["Nicotinamide-nucleotide adenylyltransferase 1","NMN adenylyltransferase 1","Nicotinate-nucleotide adenylyltransferase 1","NaMN adenylyltransferase 1"],"length_aa":279,"mass_kda":31.9,"function":"Catalyzes the formation of NAD(+) from nicotinamide mononucleotide (NMN) and ATP (PubMed:17402747). Can also use the deamidated form; nicotinic acid mononucleotide (NaMN) as substrate with the same efficiency (PubMed:17402747). Can use triazofurin monophosphate (TrMP) as substrate (PubMed:17402747). Also catalyzes the reverse reaction, i.e. the pyrophosphorolytic cleavage of NAD(+) (PubMed:17402747). For the pyrophosphorolytic activity, prefers NAD(+) and NaAD as substrates and degrades NADH, nicotinic acid adenine dinucleotide phosphate (NHD) and nicotinamide guanine dinucleotide (NGD) less effectively (PubMed:17402747). Involved in the synthesis of ATP in the nucleus, together with PARP1, PARG and NUDT5 (PubMed:27257257). Nuclear ATP generation is required for extensive chromatin remodeling events that are energy-consuming (PubMed:27257257). Also acts as a cofactor for glutamate and aspartate ADP-ribosylation by directing PARP1 catalytic activity to glutamate and aspartate residues on histones (By similarity). Fails to cleave phosphorylated dinucleotides NADP(+), NADPH and NaADP(+) (PubMed:17402747). Protects against axonal degeneration following mechanical or toxic insults (By similarity). Neural protection does not correlate with cellular NAD(+) levels but may still require enzyme activity (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9HAN9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NMNAT1","classification":"Not Classified","n_dependent_lines":312,"n_total_lines":1208,"dependency_fraction":0.2582781456953642},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HIST2H2BE","stoichiometry":0.2},{"gene":"SAE1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/NMNAT1","total_profiled":1310},"omim":[{"mim_id":"619260","title":"SPONDYLOEPIPHYSEAL DYSPLASIA, SENSORINEURAL HEARING LOSS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND LEBER CONGENITAL AMAUROSIS; SHILCA","url":"https://www.omim.org/entry/619260"},{"mim_id":"608764","title":"NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NAMPT","url":"https://www.omim.org/entry/608764"},{"mim_id":"608702","title":"NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 3; NMNAT3","url":"https://www.omim.org/entry/608702"},{"mim_id":"608701","title":"NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 2; NMNAT2","url":"https://www.omim.org/entry/608701"},{"mim_id":"608700","title":"NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 1; NMNAT1","url":"https://www.omim.org/entry/608700"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear bodies","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NMNAT1"},"hgnc":{"alias_symbol":["NMNAT","PNAT1"],"prev_symbol":["LCA9"]},"alphafold":{"accession":"Q9HAN9","domains":[{"cath_id":"3.40.50.620","chopping":"6-111_148-276","consensus_level":"high","plddt":96.6883,"start":6,"end":276}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HAN9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HAN9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HAN9-F1-predicted_aligned_error_v6.png","plddt_mean":89.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NMNAT1","jax_strain_url":"https://www.jax.org/strain/search?query=NMNAT1"},"sequence":{"accession":"Q9HAN9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9HAN9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9HAN9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HAN9"}},"corpus_meta":[{"pmid":"11770485","id":"PMC_11770485","title":"Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene.","date":"2001","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11770485","citation_count":515,"is_preprint":false},{"pmid":"20345246","id":"PMC_20345246","title":"Wallerian degeneration, wld(s), and nmnat.","date":"2010","source":"Annual review of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20345246","citation_count":384,"is_preprint":false},{"pmid":"18344983","id":"PMC_18344983","title":"NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration.","date":"2008","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/18344983","citation_count":169,"is_preprint":false},{"pmid":"22842227","id":"PMC_22842227","title":"NMNAT1 mutations cause Leber congenital amaurosis.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22842227","citation_count":163,"is_preprint":false},{"pmid":"22842230","id":"PMC_22842230","title":"Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22842230","citation_count":162,"is_preprint":false},{"pmid":"27735788","id":"PMC_27735788","title":"NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+ depletion.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/27735788","citation_count":162,"is_preprint":false},{"pmid":"23226106","id":"PMC_23226106","title":"The Highwire ubiquitin ligase promotes axonal degeneration by tuning levels of Nmnat protein.","date":"2012","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/23226106","citation_count":160,"is_preprint":false},{"pmid":"17132048","id":"PMC_17132048","title":"Drosophila NMNAT maintains neural integrity independent of its NAD synthesis activity.","date":"2006","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/17132048","citation_count":135,"is_preprint":false},{"pmid":"18463239","id":"PMC_18463239","title":"Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18463239","citation_count":128,"is_preprint":false},{"pmid":"19458223","id":"PMC_19458223","title":"Transgenic mice expressing the Nmnat1 protein manifest robust delay in axonal degeneration in vivo.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19458223","citation_count":127,"is_preprint":false},{"pmid":"19273075","id":"PMC_19273075","title":"The NMN/NaMN adenylyltransferase (NMNAT) protein family.","date":"2009","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/19273075","citation_count":120,"is_preprint":false},{"pmid":"19237597","id":"PMC_19237597","title":"Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration.","date":"2009","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19237597","citation_count":117,"is_preprint":false},{"pmid":"11248244","id":"PMC_11248244","title":"Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis.","date":"2001","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11248244","citation_count":117,"is_preprint":false},{"pmid":"22425156","id":"PMC_22425156","title":"A novel Drosophila model of nerve injury reveals an essential role of Nmnat in maintaining axonal integrity.","date":"2012","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/22425156","citation_count":117,"is_preprint":false},{"pmid":"16645633","id":"PMC_16645633","title":"NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.","date":"2006","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/16645633","citation_count":116,"is_preprint":false},{"pmid":"22842231","id":"PMC_22842231","title":"Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22842231","citation_count":108,"is_preprint":false},{"pmid":"20926655","id":"PMC_20926655","title":"Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20926655","citation_count":102,"is_preprint":false},{"pmid":"19237596","id":"PMC_19237596","title":"Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice.","date":"2009","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19237596","citation_count":98,"is_preprint":false},{"pmid":"12231635","id":"PMC_12231635","title":"Age-dependent synapse withdrawal at axotomised neuromuscular junctions in Wld(s) mutant and Ube4b/Nmnat transgenic mice.","date":"2002","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12231635","citation_count":84,"is_preprint":false},{"pmid":"21965302","id":"PMC_21965302","title":"NMNAT suppresses tau-induced neurodegeneration by promoting clearance of hyperphosphorylated tau oligomers in a Drosophila model of tauopathy.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21965302","citation_count":82,"is_preprint":false},{"pmid":"21517776","id":"PMC_21517776","title":"NMNAT expression and its relation to NAD metabolism.","date":"2011","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21517776","citation_count":75,"is_preprint":false},{"pmid":"38467179","id":"PMC_38467179","title":"Lactate enhances NMNAT1 lactylation to sustain nuclear NAD+ salvage pathway and promote survival of pancreatic adenocarcinoma cells under glucose-deprived conditions.","date":"2024","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38467179","citation_count":73,"is_preprint":false},{"pmid":"23314018","id":"PMC_23314018","title":"Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.","date":"2013","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23314018","citation_count":66,"is_preprint":false},{"pmid":"21615689","id":"PMC_21615689","title":"Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration.","date":"2011","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/21615689","citation_count":65,"is_preprint":false},{"pmid":"33107823","id":"PMC_33107823","title":"SARM1 depletion rescues NMNAT1-dependent photoreceptor cell death and retinal degeneration.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33107823","citation_count":63,"is_preprint":false},{"pmid":"23211826","id":"PMC_23211826","title":"Protection of mouse retinal ganglion cell axons and soma from glaucomatous and ischemic injury by cytoplasmic overexpression of Nmnat1.","date":"2013","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/23211826","citation_count":58,"is_preprint":false},{"pmid":"21071441","id":"PMC_21071441","title":"Axonal degeneration is blocked by nicotinamide mononucleotide adenylyltransferase (Nmnat) protein transduction into transected axons.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21071441","citation_count":57,"is_preprint":false},{"pmid":"12734549","id":"PMC_12734549","title":"Identification of a locus (LCA9) for Leber's congenital amaurosis on chromosome 1p36.","date":"2003","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/12734549","citation_count":45,"is_preprint":false},{"pmid":"21596138","id":"PMC_21596138","title":"Nmnat exerts neuroprotective effects in dendrites and axons.","date":"2011","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/21596138","citation_count":43,"is_preprint":false},{"pmid":"27207593","id":"PMC_27207593","title":"Mouse Models of NMNAT1-Leber Congenital Amaurosis (LCA9) Recapitulate Key Features of the Human Disease.","date":"2016","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/27207593","citation_count":38,"is_preprint":false},{"pmid":"26616331","id":"PMC_26616331","title":"Alternative splicing of Drosophila Nmnat functions as a switch to enhance neuroprotection under stress.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26616331","citation_count":37,"is_preprint":false},{"pmid":"26018082","id":"PMC_26018082","title":"Characterization of Leber Congenital Amaurosis-associated NMNAT1 Mutants.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26018082","citation_count":36,"is_preprint":false},{"pmid":"21517775","id":"PMC_21517775","title":"NMN/NaMN adenylyltransferase (NMNAT) and NAD kinase (NADK) inhibitors: chemistry and potential therapeutic applications.","date":"2011","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21517775","citation_count":35,"is_preprint":false},{"pmid":"27923046","id":"PMC_27923046","title":"Mitochondria and Caspases Tune Nmnat-Mediated Stabilization to Promote Axon Regeneration.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27923046","citation_count":35,"is_preprint":false},{"pmid":"23737528","id":"PMC_23737528","title":"The NAD+ synthesis enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT1) regulates ribosomal RNA transcription.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23737528","citation_count":35,"is_preprint":false},{"pmid":"24552824","id":"PMC_24552824","title":"The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target.","date":"2014","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/24552824","citation_count":34,"is_preprint":false},{"pmid":"26316326","id":"PMC_26316326","title":"Hidden Genetic Variation in LCA9-Associated Congenital Blindness Explained by 5'UTR Mutations and Copy-Number Variations of NMNAT1.","date":"2015","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/26316326","citation_count":30,"is_preprint":false},{"pmid":"17207927","id":"PMC_17207927","title":"Identification of a critical site in Wld(s): essential for Nmnat enzyme activity and axon-protective function.","date":"2006","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/17207927","citation_count":30,"is_preprint":false},{"pmid":"31484760","id":"PMC_31484760","title":"Nmnat restores neuronal integrity by neutralizing mutant Huntingtin aggregate-induced progressive toxicity.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31484760","citation_count":29,"is_preprint":false},{"pmid":"23300904","id":"PMC_23300904","title":"Simultaneous single-sample determination of NMNAT isozyme activities in mouse tissues.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23300904","citation_count":29,"is_preprint":false},{"pmid":"24759102","id":"PMC_24759102","title":"YCL047C/POF1 is a novel nicotinamide mononucleotide adenylyltransferase (NMNAT) in Saccharomyces cerevisiae.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24759102","citation_count":25,"is_preprint":false},{"pmid":"24830548","id":"PMC_24830548","title":"Nonpenetrance of the most frequent autosomal recessive leber congenital amaurosis mutation in NMNAT1.","date":"2014","source":"JAMA ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/24830548","citation_count":25,"is_preprint":false},{"pmid":"24940029","id":"PMC_24940029","title":"Novel compound heterozygous NMNAT1 variants associated with Leber congenital amaurosis.","date":"2014","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/24940029","citation_count":23,"is_preprint":false},{"pmid":"22315973","id":"PMC_22315973","title":"WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity.","date":"2012","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/22315973","citation_count":22,"is_preprint":false},{"pmid":"34919052","id":"PMC_34919052","title":"NMNAT promotes glioma growth through regulating post-translational modifications of P53 to inhibit apoptosis.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34919052","citation_count":21,"is_preprint":false},{"pmid":"17113230","id":"PMC_17113230","title":"Protection of vincristine-induced neuropathy by WldS expression and the independence of the activity of Nmnat1.","date":"2006","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/17113230","citation_count":21,"is_preprint":false},{"pmid":"34878972","id":"PMC_34878972","title":"Nuclear NAD+-biosynthetic enzyme NMNAT1 facilitates development and early survival of retinal neurons.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34878972","citation_count":20,"is_preprint":false},{"pmid":"29674119","id":"PMC_29674119","title":"NMNAT1 E257K variant, associated with Leber Congenital Amaurosis (LCA9), causes a mild retinal degeneration phenotype.","date":"2018","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/29674119","citation_count":20,"is_preprint":false},{"pmid":"29184169","id":"PMC_29184169","title":"NMNAT1 variants cause cone and cone-rod dystrophy.","date":"2017","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/29184169","citation_count":20,"is_preprint":false},{"pmid":"27547771","id":"PMC_27547771","title":"Nmnat1 protects neuronal function without altering phospho-tau pathology in a mouse model of tauopathy.","date":"2016","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/27547771","citation_count":19,"is_preprint":false},{"pmid":"34495320","id":"PMC_34495320","title":"Activation of cardiac Nmnat/NAD+/SIR2 pathways mediates endurance exercise resistance to lipotoxic cardiomyopathy in aging Drosophila.","date":"2021","source":"The Journal of experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34495320","citation_count":18,"is_preprint":false},{"pmid":"29175372","id":"PMC_29175372","title":"NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy.","date":"2017","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/29175372","citation_count":18,"is_preprint":false},{"pmid":"23264732","id":"PMC_23264732","title":"Molecular chaperones protect against JNK- and Nmnat-regulated axon degeneration in Drosophila.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/23264732","citation_count":18,"is_preprint":false},{"pmid":"23159780","id":"PMC_23159780","title":"The role of autophagy in Nmnat-mediated protection against hypoxia-induced dendrite degeneration.","date":"2012","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/23159780","citation_count":18,"is_preprint":false},{"pmid":"33709122","id":"PMC_33709122","title":"Mutant Nmnat1 leads to a retina-specific decrease of NAD+ accompanied by increased poly(ADP-ribose) in a mouse model of NMNAT1-associated retinal degeneration.","date":"2021","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33709122","citation_count":18,"is_preprint":false},{"pmid":"32533184","id":"PMC_32533184","title":"An Alu-mediated duplication in NMNAT1, involved in NAD biosynthesis, causes a novel syndrome, SHILCA, affecting multiple tissues and organs.","date":"2020","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32533184","citation_count":18,"is_preprint":false},{"pmid":"32775493","id":"PMC_32775493","title":"Gene Therapy Preserves Retinal Structure and Function in a Mouse Model of NMNAT1-Associated Retinal Degeneration.","date":"2020","source":"Molecular therapy. Methods & clinical development","url":"https://pubmed.ncbi.nlm.nih.gov/32775493","citation_count":17,"is_preprint":false},{"pmid":"29727704","id":"PMC_29727704","title":"Overexpression of Nmnat improves the adaption of health span in aging Drosophila.","date":"2018","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/29727704","citation_count":16,"is_preprint":false},{"pmid":"24787896","id":"PMC_24787896","title":"Axonal transport plays a crucial role in mediating the axon-protective effects of NmNAT.","date":"2014","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/24787896","citation_count":16,"is_preprint":false},{"pmid":"27184051","id":"PMC_27184051","title":"Nmnat 1: a Security Guard of Retinal Ganglion Cells (RGCs) in Response to High Glucose Stress.","date":"2016","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27184051","citation_count":15,"is_preprint":false},{"pmid":"28369829","id":"PMC_28369829","title":"Genome-wide linkage and sequence analysis challenge CCDC66 as a human retinal dystrophy candidate gene and support a distinct NMNAT1-related fundus phenotype.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28369829","citation_count":12,"is_preprint":false},{"pmid":"25988908","id":"PMC_25988908","title":"A novel missense NMNAT1 mutation identified in a consanguineous family with Leber congenital amaurosis by targeted next generation sequencing.","date":"2015","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/25988908","citation_count":12,"is_preprint":false},{"pmid":"30901919","id":"PMC_30901919","title":"Why is NMNAT Protective against Neuronal Cell Death and Axon Degeneration, but Inhibitory of Axon Regeneration?","date":"2019","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/30901919","citation_count":11,"is_preprint":false},{"pmid":"30004997","id":"PMC_30004997","title":"A NOVEL CASE SERIES OF NMNAT1-ASSOCIATED EARLY-ONSET RETINAL DYSTROPHY: EXTENDING THE PHENOTYPIC SPECTRUM.","date":"2021","source":"Retinal cases & brief reports","url":"https://pubmed.ncbi.nlm.nih.gov/30004997","citation_count":11,"is_preprint":false},{"pmid":"35401143","id":"PMC_35401143","title":"Human Nmnat1 Promotes Autophagic Clearance of Amyloid Plaques in a Drosophila Model of Alzheimer's Disease.","date":"2022","source":"Frontiers in aging neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35401143","citation_count":11,"is_preprint":false},{"pmid":"32632475","id":"PMC_32632475","title":"Overexpression of nicotinamide mononucleotide adenylyltransferase (nmnat) increases the growth rate, Ca2+ concentration and cellulase production in Ganoderma lucidum.","date":"2020","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/32632475","citation_count":11,"is_preprint":false},{"pmid":"31583955","id":"PMC_31583955","title":"Development of a Bioluminescent High-Throughput Screening Assay for Nicotinamide Mononucleotide Adenylyltransferase (NMNAT).","date":"2019","source":"SLAS discovery : advancing life sciences R & D","url":"https://pubmed.ncbi.nlm.nih.gov/31583955","citation_count":10,"is_preprint":false},{"pmid":"26464178","id":"PMC_26464178","title":"Clinical and genetic findings in a family with NMNAT1-associated Leber congenital amaurosis: case report and review of the literature.","date":"2015","source":"Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie","url":"https://pubmed.ncbi.nlm.nih.gov/26464178","citation_count":10,"is_preprint":false},{"pmid":"31941414","id":"PMC_31941414","title":"Effect of NMDAR-NMNAT1/2 pathway on neuronal cell damage and cognitive impairment of sevoflurane-induced aged rats.","date":"2020","source":"Neurological research","url":"https://pubmed.ncbi.nlm.nih.gov/31941414","citation_count":8,"is_preprint":false},{"pmid":"37214313","id":"PMC_37214313","title":"Expression of NMNAT1 in the photoreceptors is sufficient to prevent NMNAT1-associated retinal degeneration.","date":"2023","source":"Molecular therapy. Methods & clinical development","url":"https://pubmed.ncbi.nlm.nih.gov/37214313","citation_count":7,"is_preprint":false},{"pmid":"36332487","id":"PMC_36332487","title":"Loss of hepatic Nmnat1 has no impact on diet-induced fatty liver disease.","date":"2022","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/36332487","citation_count":7,"is_preprint":false},{"pmid":"38237740","id":"PMC_38237740","title":"Nuclear Nicotinamide Adenine Dinucleotide Deficiency by Nmnat1 Deletion Impaired Hepatic Insulin Signaling, Mitochondrial Function, and Hepatokine Expression in Mice Fed a High-Fat Diet.","date":"2024","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/38237740","citation_count":7,"is_preprint":false},{"pmid":"33447901","id":"PMC_33447901","title":"Nmnat1 Modulates Mitochondrial Oxidative Stress by Inhibiting Caspase-3 Signaling in Alzheimer's Disease.","date":"2021","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/33447901","citation_count":7,"is_preprint":false},{"pmid":"36871412","id":"PMC_36871412","title":"NMNAT1 and hereditary spastic paraplegia (HSP): expanding the phenotypic spectrum of NMNAT1 variants.","date":"2023","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/36871412","citation_count":6,"is_preprint":false},{"pmid":"34445574","id":"PMC_34445574","title":"NMNAT1 Is a Survival Factor in Actinomycin D-Induced Osteosarcoma Cell Death.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34445574","citation_count":6,"is_preprint":false},{"pmid":"30671537","id":"PMC_30671537","title":"NMNAT Proteins that Limit Wallerian Degeneration Also Regulate Critical Period Plasticity in the Visual Cortex.","date":"2019","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/30671537","citation_count":6,"is_preprint":false},{"pmid":"33668384","id":"PMC_33668384","title":"New Insights on the Genetic Basis Underlying SHILCA Syndrome: Characterization of the NMNAT1 Pathological Alterations Due to Compound Heterozygous Mutations and Identification of a Novel Alternative Isoform.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33668384","citation_count":6,"is_preprint":false},{"pmid":"37421924","id":"PMC_37421924","title":"Adipocyte NMNAT1 expression is essential for nuclear NAD+ biosynthesis but dispensable for regulating thermogenesis and whole-body energy metabolism.","date":"2023","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/37421924","citation_count":5,"is_preprint":false},{"pmid":"40577472","id":"PMC_40577472","title":"Hepatic NMNAT1 is required to defend against alcohol-associated fatty liver disease.","date":"2025","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/40577472","citation_count":4,"is_preprint":false},{"pmid":"40106551","id":"PMC_40106551","title":"PPDPF preserves integrity of proximal tubule by modulating NMNAT activity in chronic kidney diseases.","date":"2025","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/40106551","citation_count":4,"is_preprint":false},{"pmid":"39446354","id":"PMC_39446354","title":"NMNAT1 Is Essential for Human iPS Cell Differentiation to the Retinal Lineage.","date":"2024","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/39446354","citation_count":4,"is_preprint":false},{"pmid":"22088538","id":"PMC_22088538","title":"Nicotinamide mononucleotide adenylyltransferase 1 gene NMNAT1 regulates neuronal dendrite and axon morphogenesis in vitro.","date":"2011","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22088538","citation_count":4,"is_preprint":false},{"pmid":"31522116","id":"PMC_31522116","title":"MicroRNA miR-1002 Enhances NMNAT-Mediated Stress Response by Modulating Alternative Splicing.","date":"2019","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/31522116","citation_count":4,"is_preprint":false},{"pmid":"39445201","id":"PMC_39445201","title":"Identification and characterization of NMNAT1 gene mutations in an Iranian patient with Leber congenital amaurosis 9.","date":"2024","source":"Clinical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/39445201","citation_count":3,"is_preprint":false},{"pmid":"38928090","id":"PMC_38928090","title":"Nmnat1 Deficiency Causes Mitoribosome Excess in Diabetic Nephropathy Mediated by Transcriptional Repressor HIC1.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38928090","citation_count":3,"is_preprint":false},{"pmid":"37394423","id":"PMC_37394423","title":"Deletion of Nmnat1 in Skeletal Muscle Leads to the Reduction of NAD+ Levels but Has No Impact on Skeletal Muscle Morphology and Fiber Types.","date":"2023","source":"Journal of nutritional science and vitaminology","url":"https://pubmed.ncbi.nlm.nih.gov/37394423","citation_count":3,"is_preprint":false},{"pmid":"11752792","id":"PMC_11752792","title":"Crystallization and preliminary X-ray analysis of human nicotinamide mononucleotide adenylyltransferase (NMNAT).","date":"2001","source":"Acta crystallographica. Section D, Biological crystallography","url":"https://pubmed.ncbi.nlm.nih.gov/11752792","citation_count":3,"is_preprint":false},{"pmid":"29355704","id":"PMC_29355704","title":"WITHDRAWN: Regular exercise protects aging Drosophila from high-fat-diet-induced locomotor impairment, cardiac dysfunction, lifespan shortening, and Nmnat and dSir2 expression decline.","date":"2018","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/29355704","citation_count":3,"is_preprint":false},{"pmid":"26618989","id":"PMC_26618989","title":"Nmnat1-Rbp7 Is a Conserved Fusion-Protein That Combines NAD+ Catalysis of Nmnat1 with Subcellular Localization of Rbp7.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26618989","citation_count":2,"is_preprint":false},{"pmid":"40784594","id":"PMC_40784594","title":"KNOP1 interacts with NMNAT1 to govern ferroptosis and tumor growth in breast cancer via regulating FoxO1-dependent GPX4 transcription.","date":"2025","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/40784594","citation_count":1,"is_preprint":false},{"pmid":"40654636","id":"PMC_40654636","title":"NMNAT1 Binding at Promoters and Enhancers Couples NAD + Synthesis to RNA Polymerase II Engagement.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40654636","citation_count":0,"is_preprint":false},{"pmid":"41521645","id":"PMC_41521645","title":"NMNAT1 Activates Autophagy to Delay D-Galactose-Induced Aging in Cochlear Hair Cells.","date":"2026","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/41521645","citation_count":0,"is_preprint":false},{"pmid":"41838801","id":"PMC_41838801","title":"The NAD salvage pathway enzyme NMNAT-C sustains dark-phase NAD+ homeostasis in cyanobacteria.","date":"2026","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/41838801","citation_count":0,"is_preprint":false},{"pmid":"40501637","id":"PMC_40501637","title":"Oxidative DNA Damage Drives Apoptotic Photoreceptor Loss in NMNAT1 -Associated Inherited Retinal Degeneration: A Therapeutic Opportunity.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40501637","citation_count":0,"is_preprint":false},{"pmid":"39820928","id":"PMC_39820928","title":"Circ-NMNAT1 Drives Tumor Progression in Bladder Cancer by Modulating the miR-370-3p/ATXN2L Axis.","date":"2025","source":"Applied biochemistry and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/39820928","citation_count":0,"is_preprint":false},{"pmid":"41993279","id":"PMC_41993279","title":"Structural and biochemical characterization of a novel inhibitor of NMNAT1, the gatekeeper of nuclear NAD+ biosynthesis.","date":"2026","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41993279","citation_count":0,"is_preprint":false},{"pmid":"41922335","id":"PMC_41922335","title":"Oxidative DNA damage drives apoptotic photoreceptor loss in NMNAT1-associated inherited retinal degeneration: a therapeutic opportunity.","date":"2026","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/41922335","citation_count":0,"is_preprint":false},{"pmid":"42081862","id":"PMC_42081862","title":"Role of NMDAR-NMNAT in sevoflurane exposure-induced learning memory deficits.","date":"2026","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/42081862","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.05.658162","title":"Oxidative DNA Damage Drives Apoptotic Photoreceptor Loss in  <i>NMNAT1</i>  -Associated Inherited Retinal Degeneration: A Therapeutic Opportunity","date":"2025-06-06","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.05.658162","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.04.30.651499","title":"NMNAT1 Binding at Promoters and Enhancers Couples NAD  <sup>+</sup>  Synthesis to RNA Polymerase II Engagement","date":"2025-05-06","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.30.651499","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48183,"output_tokens":6608,"usd":0.121834,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15847,"output_tokens":5332,"usd":0.106268,"stage2_stop_reason":"end_turn"},"total_usd":0.228102,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"NMNAT1 (Nmnat) is the active neuroprotective component of the WldS chimeric protein (Ube4b/Nmnat fusion); the WldS protein is located predominantly in the nucleus and Nmnat enzyme activity is increased fourfold in WldS tissues, indicating axon protection is mediated through altered pyridine nucleotide metabolism.\",\n      \"method\": \"Transgenic mouse overexpression; biochemical enzyme activity assay; subcellular localization by immunofluorescence\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — identification of the protective gene, dose-dependent protection shown in transgenic mice, enzyme activity measured, replicated across multiple labs\",\n      \"pmids\": [\"11770485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Human NMNAT1 is a nuclear enzyme (confirmed by immunofluorescence of nuclear localization signal) that catalyzes NAD+ synthesis from ATP and NMN; recombinant NMNAT1 strongly inhibits PARP1 activity in vitro; endogenous and recombinant NMNAT1 are phosphorylated by nuclear kinases in nuclear extracts.\",\n      \"method\": \"Protein purification from human placenta; recombinant expression; immunofluorescence; in vitro PARP1 inhibition assay; [γ-32P]ATP phosphorylation assay in nuclear extracts\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — purified enzyme, in vitro activity assays, direct localization experiment, multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"11248244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Phe28 of mouse Nmnat1 is critical for enzymatic activity; the Phe28 point mutation in WldS completely abolishes Nmnat enzyme activity and eliminates axon-protective function, confirming that Nmnat1 enzymatic activity is required for WldS-mediated axon protection.\",\n      \"method\": \"Site-directed mutagenesis; in vitro enzyme activity assay; herpes virus-mediated neuronal expression with axon degeneration morphological assay\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — active-site mutagenesis with enzymatic and functional readout, but single lab, single paper\",\n      \"pmids\": [\"17207927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In Drosophila, enzymatically inactive NMNAT protein retains significant neuroprotective effects and rescues neurodegeneration caused by loss of nmnat, demonstrating an NAD-independent requirement of NMNAT for maintaining neuronal integrity.\",\n      \"method\": \"Forward genetic screen for nmnat loss-of-function mutations in Drosophila; rescue experiments with enzyme-dead NMNAT in vivo\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — first nmnat loss-of-function mutations in a multicellular organism, rescue with enzyme-dead protein, multiple neuron types examined\",\n      \"pmids\": [\"17132048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NMNAT displays chaperone function in biochemical assays and cultured cells; it shares structural similarity with known chaperones, is upregulated in the brain upon polyglutamine-expanded protein overexpression, and is recruited with Hsp70 into protein aggregates, acting through a proteasome-mediated pathway similar to Hsp70.\",\n      \"method\": \"Biochemical chaperone assays; cell culture; co-localization with Hsp70 in protein aggregates; proteasome pathway inhibition\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical chaperone assay plus in vivo Drosophila experiments, multiple orthogonal methods, high-impact journal\",\n      \"pmids\": [\"18344983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"WldS-mediated suppression of Wallerian degeneration requires both Nmnat1 enzymatic activity and interaction of the N16 domain of WldS with valosin-containing protein (VCP)/TER94; enzyme-dead versions of Nmnat1 and WldS exhibit severely reduced axon-protective function in Drosophila.\",\n      \"method\": \"In vivo Drosophila axon protection assay; enzyme-dead mutant analysis; N16 domain deletion and VCP-binding domain replacement\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple domain mutants tested in vivo, VCP interaction confirmed by domain swap, replicated in complementary mouse paper (PMID 19237596)\",\n      \"pmids\": [\"19237597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In mice, WldS requires both Nmnat1 enzymatic activity and the VCP-binding sequence from the N-terminal Ube4b domain for axon protection; removing the VCP-binding sequence abolishes protection, and replacing it with an ataxin-3-derived VCP-binding sequence restores it; enzyme-dead WldS cannot delay Wallerian degeneration in vivo.\",\n      \"method\": \"In vivo transgenic mouse sciatic nerve transection model; VCP-binding domain deletion and substitution mutants\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo mouse experiments with multiple domain mutants, complementary to Drosophila study (PMID 19237597)\",\n      \"pmids\": [\"19237596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Cytoplasmic/axonally localized Nmnat1 (cytNmnat1) is sufficient to delay Wallerian degeneration in vivo in transgenic mice without any Ube4b sequences, demonstrating that Nmnat enzymatic activity outside the nucleus is required and sufficient for axon protection.\",\n      \"method\": \"Transgenic mouse generation with cytoplasmic-targeted Nmnat1; sciatic nerve transection; microscopic analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo transgenic mouse model with engineered localization mutant, clear phenotypic readout\",\n      \"pmids\": [\"19458223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Axonal targeting of NMNAT1 activity is both necessary and sufficient for axon protection; fusing an axonal targeting peptide from APP to NMNAT1 with disrupted nuclear localization transforms it from an ineffective molecule into one more potent than WldS in transgenic mice; axonally targeted NMNAT1 localizes to vesicular structures and co-transports at least partially with mitochondria.\",\n      \"method\": \"Transgenic mouse generation; axonal targeting peptide fusion; subcellular localization by live imaging; sciatic nerve transection assay\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo transgenic mouse experiment with engineered subcellular localization, multiple orthogonal methods, functional and localization readout\",\n      \"pmids\": [\"20926655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Transduction of Nmnat protein directly into severed axons via virus-like particles prevents axonal degeneration post-injury, establishing that Nmnat's protective effects occur locally within the axon.\",\n      \"method\": \"Protein transduction via virus-like particles into transected axons; in vitro axon degeneration assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct protein transduction into axons is a novel method establishing local axonal action, single lab single study\",\n      \"pmids\": [\"21071441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NMNAT1 interacts with the nucleolar repressor nucleomethylin and is recruited into a ternary complex containing SirT1; NMNAT1 expression stimulates the deacetylase function of SirT1; NMNAT1 is involved in repressing rRNA transcription, and knockdown enhances rRNA transcription and promotes cell death after nutrient deprivation.\",\n      \"method\": \"Co-immunoprecipitation; knockdown; rRNA transcription assay; SirT1 deacetylase activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — reciprocal Co-IP and functional enzyme assay, single lab, moderate mechanistic follow-up\",\n      \"pmids\": [\"23737528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Loss-of-function mutations in NMNAT1 (LCA9 locus) cause Leber congenital amaurosis; the disease-causing p.Val9Met mutation decreases NMNAT1 enzyme activity, establishing that reduced NAD+ biosynthetic activity of NMNAT1 underlies retinal degeneration.\",\n      \"method\": \"Exome sequencing; functional enzyme activity assay of mutant NMNAT1 protein\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — functional enzymatic assay of mutant protein, replicated in three independent papers in the same journal issue (PMIDs 22842227, 22842230, 22842231)\",\n      \"pmids\": [\"22842227\", \"22842230\", \"22842231\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"LCA-causing NMNAT1 mutations reduce enzymatic activity and affect protein folding, as assessed by functional assays of mutant alleles.\",\n      \"method\": \"Functional enzyme activity assay; protein folding assessment of LCA mutant proteins\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro enzyme assay plus protein folding analysis, replicated across independent cohort papers\",\n      \"pmids\": [\"22842230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The E3 ubiquitin ligase Highwire (Hiw) promotes rapid degradation of Nmnat protein in the distal axon stump after injury; increased Nmnat protein levels in hiw mutants are both required and sufficient to inhibit Wallerian degeneration, placing Nmnat downstream of Hiw in the axon degeneration pathway.\",\n      \"method\": \"Drosophila genetic epistasis; hiw loss-of-function and gain-of-function; protein level measurement by western blot; in vivo axon degeneration assay\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with multiple neuron types and developmental stages, rescue experiments, mechanistic pathway placement\",\n      \"pmids\": [\"23226106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NMNAT1 overexpression protects injured axons by blocking SARM1-dependent NAD+ consumption (rather than by increasing NAD+ synthesis); using steady-state and flux analysis, NMNAT1 was found to inhibit injury-induced, SARM1-mediated NAD+ depletion that is central to axon degeneration.\",\n      \"method\": \"Steady-state and metabolic flux analysis of NAD+ metabolites in mouse DRG axons; SARM1 genetic manipulation\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — metabolic flux analysis with genetic manipulation of SARM1, mechanistic pathway placement, rigorous quantitative methods\",\n      \"pmids\": [\"27735788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NMNAT1 loss in photoreceptors activates the NADase SARM1 (the central executioner of axon degeneration), triggering photoreceptor death; SARM1 depletion rescues photoreceptor loss in NMNAT1-deficient retinas, establishing that NMNAT1's essential function in photoreceptors is to inhibit SARM1.\",\n      \"method\": \"Conditional knockout mice; SARM1 genetic depletion rescue experiment; photoreceptor-specific conditional deletion\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with genetic rescue by SARM1 depletion, multiple mouse models, clear mechanistic pathway\",\n      \"pmids\": [\"33107823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Most LCA-associated NMNAT1 mutants have normal enzymatic activity under standard conditions, but their secondary structure is less thermally stable (they lose activity after heat shock while wild-type retains activity), suggesting protein instability rather than direct loss of catalytic activity is a mechanism underlying retinal degeneration.\",\n      \"method\": \"Recombinant protein expression; enzyme activity assay; heat shock stability assay; secondary structure analysis; oligomerization assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — multiple biochemical assays on LCA mutants, single lab, comprehensive but not independently replicated\",\n      \"pmids\": [\"26018082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NMNAT overexpression suppresses tauopathy-induced neurodegeneration by reducing hyperphosphorylated tau oligomer levels; NMNAT interacts with phosphorylated tau in vivo and promotes ubiquitination and clearance of toxic tau species; this protective activity is independent of NAD synthesis activity, indicating direct protein-protein interaction.\",\n      \"method\": \"Drosophila tauopathy model; overexpression with enzyme-dead NMNAT; co-immunoprecipitation with phospho-tau in vivo; ubiquitination assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP in vivo plus enzyme-dead rescue plus ubiquitination assay, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"21965302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NMNAT promotes autophagic clearance of mutant Huntingtin aggregates in Drosophila HD models; it reduces the amyloid-like adhesive property of Htt aggregates and inhibits their clustering with mitochondria and synaptic proteins; partial loss of endogenous Nmnat exacerbates mutant Htt-induced neurodegeneration.\",\n      \"method\": \"Drosophila HD model; Nmnat overexpression and partial loss-of-function; autophagy assay; thioflavin S staining for amyloid-like aggregates; mitochondrial clustering analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple Drosophila genetic approaches with orthogonal readouts, single lab\",\n      \"pmids\": [\"31484760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NMNAT interferes with the DNA damage-p53-caspase-3 apoptosis pathway by enhancing NAD+-dependent post-translational modifications: PARylation and deacetylation of p53, which reduce p53 pro-apoptotic activity; NMNAT forms a protein complex with p53 and NAD+-dependent PTM enzymes.\",\n      \"method\": \"Drosophila glial neoplasia model and human glioma cells; co-immunoprecipitation; p53 PARylation and deacetylation assays; enzyme-dead NMNAT controls\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus functional PTM assays in two model systems, single lab\",\n      \"pmids\": [\"34919052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NMNAT1 knockout in the developing murine retina causes disruptions to central carbon metabolism, purine nucleotide synthesis, and amino acid pathways; transcriptomic analysis reveals dysregulation of photoreceptor and synapse-specific genes prior to detectable morphological or metabolic changes, suggesting a role in gene regulation during photoreceptor terminal differentiation.\",\n      \"method\": \"Conditional knockout mice; transcriptomics (RNA-seq); metabolomics; immunostaining\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with transcriptomic and metabolomic analysis, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"34878972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NMNAT1 loss in photoreceptors leads to a retina-specific decrease in NAD+ and overproduction of poly(ADP-ribose) (PAR) by PARP in photoreceptors, while nuclear sirtuin deacetylation activity is not altered; photoreceptors ultimately die by apoptosis, with aspects of the parthanatos pathway.\",\n      \"method\": \"Mouse model (p.Val9Met); LC-MS/MS quantification of NAD+; PARP activity assay; PAR immunostaining; TUNEL staining\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — quantitative metabolite measurement plus PARP activity assay, single lab single paper\",\n      \"pmids\": [\"33709122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NMNAT1 is lactylated at Lys128 by the lactyltransferase EP300; lactylation of NMNAT1 enhances its nuclear localization and maintains its enzymatic activity, thereby supporting the nuclear NAD+ salvage pathway in pancreatic cancer cells under glucose deprivation.\",\n      \"method\": \"Multi-omics analysis; site-directed mutagenesis at K128; RNA interference; co-immunoprecipitation with EP300; subcellular fractionation; enzyme activity assay\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-directed mutagenesis identifying modification site, EP300 identified as writer by Co-IP, functional enzyme and localization assays, single lab\",\n      \"pmids\": [\"38467179\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NMNAT1 is essential for human iPSC differentiation to the retinal lineage; NMNAT1-KO organoids fail to induce RAX and form retinal primordial structures; NMNAT1-KO leads to decreased NAD+ levels and reduced PARylation of PARP1, identifying a NMNAT1-NAD-PARP1 axis in retinal fate commitment.\",\n      \"method\": \"CRISPR/Cas9 NMNAT1-KO human iPSC retinal organoids; transcriptomic analysis; mass spectrometry of PARylated proteins; intracellular NAD measurement\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO in human iPSCs with multiple orthogonal readouts, single lab\",\n      \"pmids\": [\"39446354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Human NMNAT1 was crystallized in the presence of NAD+; crystals diffract to 3.0 Å resolution, and packing considerations suggest a hexameric assembly in the asymmetric unit, consistent with archaeal NMNAT hexamers.\",\n      \"method\": \"Protein crystallization; preliminary X-ray diffraction analysis\",\n      \"journal\": \"Acta crystallographica Section D\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 1 / Weak — preliminary crystallography only, no functional validation, resolution insufficient for full structure determination at this stage\",\n      \"pmids\": [\"11752792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NMNAT1 binds to promoters and enhancers of actively transcribed genes genome-wide; NMNAT1 knockout reduces RNA Polymerase II occupancy at downregulated genes, positioning NMNAT1 as coupling localized NAD+ production to gene-specific transcriptional activation through Pol II engagement.\",\n      \"method\": \"CUT&Tag (genome-wide NMNAT1 binding); RNA-seq; NMNAT1 knockout cells; multi-omics integration\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — CUT&Tag plus RNA-seq in KO cells, preprint not yet peer-reviewed, single lab\",\n      \"pmids\": [\"40654636\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"AMI-1 (a known PRMT1 inhibitor) also inhibits NMNAT1; cryo-EM structure of NMNAT1 bound to AMI-1 reveals its mechanism of inhibition at atomic resolution.\",\n      \"method\": \"Cryo-EM structure determination; biochemical inhibition assay; NAD+ level measurement in NMNAT1-dependent cancer cells\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — cryo-EM structure with functional inhibition assay, preprint not peer-reviewed, single lab\",\n      \"pmids\": [\"41993279\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"KNOP1 directly interacts with NMNAT1 to maintain intracellular NAD+ homeostasis; this interaction inhibits FoxO1 phosphorylation and promotes its nuclear retention, facilitating GPX4 transcription and suppressing ferroptosis in breast cancer cells; NMNAT1 knockdown disrupts this axis by inducing FoxO1 nuclear export and GPX4 downregulation.\",\n      \"method\": \"Co-immunoprecipitation; ChIP; NAD+ quantification; RNA interference; rescue experiments with Ferrostatin-1 and NMNAT1 overexpression\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus ChIP plus rescue experiments, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"40784594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Reduced NMNAT1 function (p.V9M mutation) leads to accumulation of oxidative DNA adduct 8-oxo-dG and DNA double-strand breaks in photoreceptors, followed by caspase-9-mediated apoptosis; necroptosis and parthanatos pathways are not significantly activated; treatment with antioxidant NAC reduces oxidative DNA damage and preserves photoreceptor structure and function.\",\n      \"method\": \"Nmnat1 V9M/V9M knock-in mice; 8-oxo-dG immunostaining; γH2AX staining; caspase-9 activation assay; TUNEL; NAC treatment; OCT and ERG\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal cell death pathway assays in knock-in mouse model with therapeutic intervention, single lab\",\n      \"pmids\": [\"41922335\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NMNAT1 is a nuclear NAD+-synthesizing enzyme (catalyzing the adenylylation of NMN to NAD+) that maintains nuclear NAD+ homeostasis and protects neurons—particularly retinal photoreceptors—by inhibiting the NADase SARM1 and thereby blocking injury- or stress-induced NAD+ depletion; it also functions as a molecular chaperone independent of its enzymatic activity, promotes clearance of misfolded proteins via autophagy and the ubiquitin-proteasome system, stimulates SirT1 deacetylase activity within a nucleomethylin-containing complex to repress rRNA transcription, and binds promoters/enhancers to couple local NAD+ production to RNA Polymerase II engagement, while its axon-protective activity requires cytoplasmic/axonal localization and is regulated by Highwire-mediated ubiquitin-dependent degradation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NMNAT1 is a nuclear enzyme that synthesizes NAD+ from ATP and NMN and serves as a central guardian of neuronal integrity and NAD+ homeostasis [#1, #0]. Its identification as the active component of the WldS axon-protective fusion protein established that altered pyridine nucleotide metabolism delays axon degeneration, with enzymatic activity required for this protection [#0, #2, #5]. Although NMNAT1 is constitutively nuclear, its axon-protective function depends on activity localized outside the nucleus: cytoplasmic and axonally targeted NMNAT1 is sufficient to delay Wallerian degeneration and acts locally within the axon [#7, #8, #9]. Mechanistically, NMNAT1 protects injured axons not by boosting NAD+ synthesis but by blocking SARM1-dependent NAD+ depletion, the central degenerative trigger; loss of NMNAT1 activates the NADase SARM1, and SARM1 depletion rescues photoreceptor death in NMNAT1-deficient retinas [#14, #15]. Independent of its catalytic activity, NMNAT1 functions as a molecular chaperone that is recruited with Hsp70 into protein aggregates and promotes clearance of misfolded proteins, including phospho-tau and mutant Huntingtin, through the ubiquitin-proteasome system and autophagy [#4, #17, #18]. In the nucleus, NMNAT1 couples local NAD+ production to gene regulation: it associates with the nucleomethylin/SirT1 complex to repress rRNA transcription, stimulates SirT1 deacetylase activity, and dampens p53-driven apoptosis via NAD+-dependent PARylation and deacetylation [#10, #19]. In humans, loss-of-function mutations in NMNAT1 cause Leber congenital amaurosis, with disease alleles reducing enzymatic activity and/or destabilizing the protein [#11, #12, #16]; in the retina, NMNAT1 deficiency drives NAD+ decline, oxidative DNA damage, and photoreceptor apoptosis [#21, #28].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Established that NMNAT1 is the functional neuroprotective effector of the WldS protein, linking axon protection to NAD+ metabolism, and defined NMNAT1 as a nuclear NAD+-synthesizing enzyme.\",\n      \"evidence\": \"Transgenic mouse overexpression with enzyme activity assays and immunofluorescence; protein purification from human placenta with in vitro NAD+ synthesis and PARP1 inhibition assays\",\n      \"pmids\": [\"11770485\", \"11248244\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nuclear localization seemed incompatible with axon protection occurring in the cytoplasm\", \"Whether enzymatic activity per se was required was not yet resolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Tested whether catalysis is required for protection, with conflicting answers that defined a dual-function model: enzyme activity is needed for WldS axon protection in mice, yet enzyme-dead NMNAT still rescues neurodegeneration in Drosophila.\",\n      \"evidence\": \"Site-directed active-site mutagenesis (Phe28) with neuronal axon degeneration assays in mice; forward genetic loss-of-function screen and enzyme-dead rescue in Drosophila\",\n      \"pmids\": [\"17207927\", \"17132048\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The molecular basis of the NAD-independent neuroprotective activity was undefined\", \"Did not resolve whether the two activities act in the same or different cell compartments\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified the NAD-independent activity as a chaperone function, explaining how NMNAT can protect neurons without synthesizing NAD+.\",\n      \"evidence\": \"Biochemical chaperone assays, co-localization with Hsp70 in aggregates, and proteasome pathway inhibition in cultured cells\",\n      \"pmids\": [\"18344983\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The structural determinants of chaperone activity were not mapped\", \"Direct substrate range of the chaperone function was not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Dissected the WldS protective module, showing protection requires both NMNAT1 catalysis and the N16/Ube4b VCP-binding sequence, and that cytoplasmic NMNAT1 alone suffices for axon protection.\",\n      \"evidence\": \"In vivo Drosophila and transgenic mouse axon protection assays with domain deletions, VCP-binding domain swaps, enzyme-dead mutants, and cytoplasmic-targeted NMNAT1\",\n      \"pmids\": [\"19237597\", \"19237596\", \"19458223\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How VCP interaction mechanistically cooperates with NAD+ synthesis was not established\", \"The endogenous compartment in which NMNAT1 acts during physiological injury was unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated that axonal/local targeting of NMNAT1 activity is necessary and sufficient and that protection occurs locally within the axon, refining where the enzyme must act.\",\n      \"evidence\": \"Transgenic mice with axonal targeting peptide fusions and disrupted NLS, live imaging of vesicular/mitochondrial co-transport; protein transduction into severed axons via virus-like particles\",\n      \"pmids\": [\"20926655\", \"21071441\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The axonal vesicular/mitochondrial association mechanism was not molecularly defined\", \"Protein-transduction study was a single-lab in vitro demonstration\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected nuclear NMNAT1 to gene regulation and protein clearance, showing it stimulates SirT1 to repress rRNA transcription and promotes ubiquitin-dependent clearance of toxic phospho-tau independent of NAD synthesis.\",\n      \"evidence\": \"Co-immunoprecipitation, knockdown, rRNA transcription and SirT1 deacetylase assays; Drosophila tauopathy model with enzyme-dead NMNAT, in vivo phospho-tau Co-IP and ubiquitination assays\",\n      \"pmids\": [\"23737528\", \"21965302\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab Co-IP evidence without structural detail of the ternary complex\", \"Whether SirT1 stimulation and tau clearance operate in the same pathway is unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Established NMNAT1 as a Mendelian disease gene, showing loss-of-function mutations cause Leber congenital amaurosis through reduced NAD+ biosynthetic activity and impaired protein folding.\",\n      \"evidence\": \"Exome sequencing of LCA patients and functional enzyme activity plus protein folding assays of mutant alleles, replicated across independent cohort papers\",\n      \"pmids\": [\"22842227\", \"22842230\", \"22842231\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why a ubiquitous enzyme causes a retina-specific disease was unexplained\", \"The downstream degenerative pathway in photoreceptors was not yet defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Placed NMNAT in an injury-signaling pathway by showing the E3 ligase Highwire drives its rapid post-injury degradation, identifying regulated NMNAT turnover as a control point for axon degeneration.\",\n      \"evidence\": \"Drosophila genetic epistasis with hiw loss- and gain-of-function, protein-level western blots, and in vivo axon degeneration assays\",\n      \"pmids\": [\"23226106\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether a mammalian Highwire ortholog regulates NMNAT1 the same way was not tested here\", \"The signal triggering Hiw-dependent NMNAT degradation was unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Redefined the protective mechanism, showing NMNAT1 prevents axon degeneration by blocking SARM1-mediated NAD+ depletion rather than by net NAD+ synthesis.\",\n      \"evidence\": \"Steady-state and metabolic flux analysis of NAD+ metabolites in mouse DRG axons with SARM1 genetic manipulation\",\n      \"pmids\": [\"27735788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The direct biochemical relationship between NMNAT1 and SARM1 was not structurally resolved\", \"How NMNAT1 levels are coupled to SARM1 activation kinetics was not detailed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Refined the disease mechanism by showing most LCA mutants retain catalytic activity but are thermally unstable, implicating protein destabilization rather than direct catalytic loss.\",\n      \"evidence\": \"Recombinant mutant protein enzyme, heat-shock stability, secondary structure, and oligomerization assays\",\n      \"pmids\": [\"26018082\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab biochemistry not independently replicated\", \"Did not test instability in photoreceptors in vivo\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified SARM1 inhibition as the essential function of NMNAT1 in photoreceptors, explaining retinal vulnerability in NMNAT1 deficiency.\",\n      \"evidence\": \"Photoreceptor-specific conditional knockout mice with genetic SARM1-depletion rescue\",\n      \"pmids\": [\"33107823\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SARM1 fully accounts for human LCA pathology was not established\", \"The relative contribution of nuclear vs cytoplasmic NMNAT1 in photoreceptors was not dissected\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Expanded the functional repertoire to autophagic aggregate clearance, p53/apoptosis regulation, and photoreceptor metabolic/transcriptional roles, and detailed retinal degeneration involving NAD+ decline and PARP overactivation.\",\n      \"evidence\": \"Drosophila HD and glioma models with autophagy, PARylation/deacetylation and Co-IP assays; conditional KO retinal transcriptomics/metabolomics; mouse p.Val9Met NAD+/PARP/PAR/TUNEL analyses\",\n      \"pmids\": [\"31484760\", \"34919052\", \"34878972\", \"33709122\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"These roles rest largely on single-lab studies in disparate model systems\", \"How nuclear NAD+ depletion mechanistically links to PARP overactivation and cell death is incompletely defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Began defining regulation and chromatin-coupled roles of NMNAT1, showing EP300-mediated lactylation maintains nuclear activity, NMNAT1 is required for retinal lineage commitment via a NAD-PARP1 axis, and it binds active promoters to couple NAD+ production to Pol II engagement.\",\n      \"evidence\": \"Lactylation site mutagenesis with EP300 Co-IP and fractionation; CRISPR-KO iPSC retinal organoids with NAD+/PARylation readouts; CUT&Tag with RNA-seq in KO cells (preprint)\",\n      \"pmids\": [\"38467179\", \"39446354\", \"40654636\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The genome-wide chromatin-binding model derives from a preprint\", \"How NMNAT1 is recruited to specific promoters/enhancers is unknown\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Advanced structural and cell-death mechanism understanding, providing a cryo-EM structure of inhibitor-bound NMNAT1 and showing the V9M retinal phenotype proceeds via oxidative DNA damage and caspase-9 apoptosis rescuable by antioxidant treatment.\",\n      \"evidence\": \"Cryo-EM of NMNAT1-AMI-1 with biochemical inhibition assays (preprint); V9M knock-in mice with 8-oxo-dG, γH2AX, caspase-9, TUNEL assays and NAC intervention\",\n      \"pmids\": [\"41993279\", \"41922335\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cryo-EM inhibitor study is a non-peer-reviewed preprint\", \"Reconciling the oxidative-DNA-damage/caspase-9 mechanism with the SARM1-dependent model remains open\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How NMNAT1's distinct activities — nuclear NAD+ synthesis, SARM1 inhibition, NAD-independent chaperone/aggregate clearance, and promoter-coupled transcriptional regulation — are integrated, compartmentally partitioned, and selectively deployed in a cell-type-specific manner remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified structural/mechanistic model links NMNAT1's enzymatic and chaperone functions\", \"The basis for retina-specific vulnerability despite ubiquitous expression is incompletely explained\", \"Direct physical interaction mode with SARM1 is undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [1, 0, 11]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [4, 17, 18]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 10, 14]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 0]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [7, 8]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:1430728\", \"supporting_discovery_ids\": [1, 14, 20]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 14, 20]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [19, 28, 21]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [11, 12, 15]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [10, 25]}\n    ],\n    \"complexes\": [\"nucleomethylin/SirT1 complex\"],\n    \"partners\": [\"SARM1\", \"PARP1\", \"SIRT1\", \"VCP\", \"HSP70\", \"EP300\", \"TP53\", \"KNOP1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}